BofA/Merrill Lynch Upgrades Edwards Lifesciences (EW) to Buy

BofA/Merrill Lynch upgraded Edwards Lifesciences (NYSE: EW) from Neutral to Buy with a price target of $130.00.

For an analyst ratings summary and ratings history on Edwards Lifesciences click here. For more ratings news on Edwards Lifesciences click here.

Shares of Edwards Lifesciences closed at $108.35 yesterday.

You May Also Be Interested In

• BofA Securities Upgrades Equinor ASA (ADR) (EQNR) to Buy
• Erste Group Upgrades Toyota Motor (TM) to Buy, 'more profitable than its competitors'
• US Financial 15 Split Corp. declares $0.07883 monthly preferred dividend